Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.8MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
Sector
Industry
History
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information
Ticker
PMCBCompany Name
PHARMACYTE BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPHARMACYTE BIOTECH INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PMCB - CF - Equity Historical data
| Date | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|
| 6/30/2025 | $ -1.8M |
| 3/31/2025 | $ -2.54M |
| 12/31/2024 | $ -3.55M |
| 9/30/2024 | $ -3.72M |
| 6/30/2024 | $ -2.48M |
| 3/31/2024 | $ -28.2M |
| 12/31/2023 | $ -31.33M |
| 9/30/2023 | $ -34.71M |
| 6/30/2023 | $ -37.93M |
| 3/31/2023 | $ -13.56M |
Key Performance Insights, Last 5 Years
- PHARMACYTE BIOTECH INC's latest trailing twelve months (TTM) CF - Equity stands at $ 6.48M.
- Over the past 5 years, PHARMACYTE BIOTECH INC's average CF - Equity has been $ 9.64M.
- The median CF - Equity for PHARMACYTE BIOTECH INC during this period was $ -2.51M
- PHARMACYTE BIOTECH INC reached its highest CF - Equity over the past 5 years at $ 87.36M.
- The lowest CF - Equity recorded by PHARMACYTE BIOTECH INC in the same timeframe $ -37.93M
Similar metrics to CF - Equity:
- Net Cash Flow - Issuance (Repayment) of Debt Securities - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from issuance (repayment) of debt.
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Net Cash Flow - Dividends & Other Cash Distributions - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing dividends and dividend equivalents paid on common stock and restricted stock units.
- Buyback Yield - [Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
- Net Cash Flow - Business Acquisitions and Disposals - [Cash Flow Statement] A component of cash flow from investing [NCFI], representing the net amount of cash to acquire (outflow) or dispose (inflow) businesses, join-ventures, affiliates or other investments.
Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares
[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).PMCB - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years
$ -37.93M
Minimum
Jun 30, 2023
$ 87.36M
Maximum
Sep 30, 2021
$ 9.64M
Average
$ -2.51M
Median
CF - Equity Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 94.74K with a standard deviation of $ 17.64M.
The following table provides additional summary stats:
CF - Equity in the Market:
| filtered constituents | 2.89K |
|---|---|
| min | $ -60.59M |
| max | $ 60.64M |
| average | $ 94.74K |
| median | $ 0 |
| std | $ 17.64M |